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Abstract
Stem cells have become the fundamental element in 
regenerative medicine due to their inherent potential to 
differentiate into various cell types, and the ability to 
produce various bioactive molecules, including growth 
factors, cytokines and extracellular matrix molecules. 
In vivo, the secretion of tropic factors is modulated by 
chemotactic and inflammatory factors. In this study, we 
analysed the influence of a 2 h stimulation of mesenchymal 
stem cells (MSCs) with interleukin-1β (IL1β), granulocyte-
colony stimulating factor (GCSF), stromal cell-derived 
factor 1 (SDF1) and stem cell factor (SCF). Our results 
demonstrated that this short stimulation exerts pronounced 
effects on the expression of multiple cytokine genes and 
proteins in MSC cells 48 and 72 h later. IL1β strongly 
promoted the secretion of a wide range of proteins with 
chemotactic, proinflammatory and angiogenic properties, 
whereas SCF regulated the expression of proteins involved 
in proliferation, chondrogenesis and ECM regulation. This 
demonstrates that the changes in secretome can be directed 
towards a desired final functional outcome by selection of 
the most appropriate cytokine. Moreover, the expression 
pattern of Wnt signalling pathway components suggested 
the differential regulation of this pathway by IL1β and 
SCF. Altogether, the robust paracrine action of MSCs 
can be achieved within a just 2 h treatment, which would 
be feasible within the operating theatre during a single 
surgical procedure. These results suggest that integrating 
inflammatory modulation in bone tissue engineering, by 
modifying the MSC secretome by way of a short stimulus, 
would provide a more targeted approach than administering 
unmodified MSCs alone.
Keywords: Bone repair, stem cells, cytokines, inflammation, 
tissue engineering.
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Introduction
Various strategies have been developed and applied to 
aid the regeneration process of the injured tissue. These 
include separate or combined implantation of specific 
cell types, biomaterials and factors. Cell therapy alone, 
or in combination with supportive biomaterials and 
factors, is of particular interest for clinical application to 
treat a wide array of acute or chronic conditions due to 
the inherent potential of stem cells to differentiate into 
various cell types (Pittenger et al., 1999). Currently, more 
than 4,500 ongoing clinical trials have been registered 
worldwide (www.clinicaltrail.gov) using stem cells, and 
approximately 10 % of these use MSCs. Specifically, much 
attention and hope is invested into single surgical procedure 
cell therapies. This strategy integrates the autologous cell 
harvesting, processing and re-implantation into the injured 
site within the operation theatre. Intraoperative autologous 
stem cell therapy brings advantages regarding the usage 
of patient’s own cells, thus avoiding the activation of an 
immune response, extensive in vitro cell expansion and 
manipulation, requirements for Good Manufacture Practice 
facilities, a secondary invasive procedure and potential 
contamination (Coelho et al., 2012).
 In addition to their direct contribution to tissue 
regeneration, as a consequence of differentiation into 
specific phenotype, implanted cells aid regeneration by 
producing various bioactive molecules, including growth 
factors, cytokines and extracellular matrix molecules 
(Tsiridis et al., 2007; Zhukareva et al., 2010; Hsiao et al., 
2012). These secreted factors act in an auto- and paracrine 
manner regulating cell phenotype. The importance of 
paracrine actions in the host tissue have been studied 
extensively in repair and regeneration of the central 
nervous system (Drago et al., 2013), heart (Gnecchi et 
al., 2006; Hwang et al., 2012) and skin (Schlosser et al., 
2012). The indirect action of progenitor cells implanted 
within the bone-healing environment is less understood; 
nevertheless, the importance of various factors secreted 
by cells present in fracture milieu is known to have great 
importance on bone regeneration.
 The importance of inflammation occurring after bone 
fracture has been demonstrated directly by the increased 
levels of various factors at the molecular and protein level, 
as well as indirectly by removing the fracture haematoma 
(Kolar et al., 2011). Combating inflammation and, as 
consequence, the wide spectrum of factors secreted by 
immune and progenitor cells present at the fracture site has 
also been shown to have a role (Simon et al., 2002). The 
local increased levels of mRNA expression of interleukin 8 
(IL8), vascular endothelial growth factor (VEGF) together 
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with interleukin 6 (IL6), CXC chemokine receptor type 4 
(CXCR4) and secreted phosphoprotein 1 (SPP1) in fracture 
haematoma indicate their importance for chemotaxis, 
angiogenesis and osteogenesis (Kolar et al., 2011).
 The removal of the haematoma, together with cells 
contained within, or combating inflammation with non-
steroid anti-inflammatory drugs, prolonged the time of 
fracture healing compared to fracture with haematoma 
(Simon et al., 2002; Kolar et al., 2011; Mountziaris et al., 
2011).
 In order to increase the production of specific 
factors by cells strategies such as genetic engineering 
and preconditioning of cells have been applied. Since 
the secretion of tropic factors is modulated in vivo by 
cytokines, their use could provide a strategy to enhance 
the paracrine actions of cells prior to their implantation. 
This could enhance their function during the critical 
early time points. Driven by this hypothesis we selected 
four factors which are players in the early stages of the 
bone healing cascade, including interleukin 1β (IL1β), 
granulocyte-colony stimulating factor (GCSF), stromal 
cell-derived factor 1 (SDF1) and stem cell factor (SCF), to 
determine the cytokine profile of mesenchymal stem cells 
(MSCs) after transient stimulation with these factors. IL1β 
would be expected to lead to a change in the expression of 
inflammatory modifying cytokines. SDF1 was chosen as it 
is known for its effects on chemotaxis, but little is known 
about whether the factor changes the phenotype of the cells 
as well. GCSF and CSF have been proposed in rabbits to 
be involved in proliferation and self-renewal (Tang et al., 
2009), and so would be expected to cause the release of 
mitogenic factors.
Materials and Methods
Human bone marrow MSCs isolation
Human bone marrow aspirates were obtained from the iliac 
crest of nine patients following ethical approval (KEK-ZH-
Nr: 2010-04444/0) and with the written consent of donors. 
Nine donors were used (Mean age: 43 years; range: 18-65 
years; 7 females and 2 males, Table 1). Mesenchymal stem 
cells (MSCs) were isolated and expanded as previously 
described (Li et al., 2009). In brief, the mononuclear cell 
fraction of whole marrow aspirate was isolated using 
a Ficol density gradient. Isolated cells were seeded at 
a density of ~50,000 cells/cm2 in α-Minimal Essential 
Medium (αMEM, Gibco/Life Technologies) medium with 
10% MSC tested serum (Biochrom/Merck, Darmstadt, 
Germany) + 5 ng/mL basic fibroblast growth factor (bFGF, 
Fitzgerald Industries International). Cells were left to attach 
for 4 days and the medium is then replaced three times per 
week. Cells were harvested by trypsinisation at 60-80 % 
confluence and reseeded at 3000 cells/cm2. Cells from all 
donors were tested to confirm differentiation potential into 
chondrocytes, adipocytes and osteoblasts (data not shown).
MSCs stimulation
MSCs (6.082 ± 0.83 population doublings after 
cryopreservation) were plated at a density of 15,000 
cells/cm2 in cell culture polystyrene flasks and cultured 
in Dulbecco’s Modified Eagle’s Medium (DMEM) 
low glucose (Gibco/Life Technologies/Thermo Fisher 
Scientific, Zug, Switzerland) supplemented with 10 % FCS 
(Gibco/Life Technologies) and 1 % penicillin/streptomycin 
(Gibco/Life Technologies) overnight. Two experimental 
designs for cell stimulation were applied as presented in 
Fig. 1. On the day of stimulation, medium was aspirated 
and fresh medium containing 10 ng/mL IL1β, 100 ng/
mL SCF, 100 ng/mL GCSF or 1 μg/mL SDF1 (all from 
PromoCell, Heidelberg, Germany) was added. As negative 
controls, cells were kept in medium without any factor. 
After 2 h, medium was aspirated and cells were washed 
with phosphate buffered saline (PBS) to ensure complete 
removal of the factors.
 An initial screen at the mRNA level was performed 
at 72 h to ensure an effect of short-term stimulation 
could be observed. In this initial set of experiments, cells 
were maintained at 37 °C and 5 % CO2 in DMEM low 
glucose with 10 % foetal calf serum (FCS) (to prevent cell 
death) and 1 % penicillin/streptomycin. A second set of 
experiments to investigate mRNA expression and secreted 
protein analysis, was also carried out. In the second set of 
experiments, cells were cultured for 48 h at 37 °C and 5 % 
CO2 in serum-free DMEM low glucose with 1 % penicillin/
Table 1. Human bone marrow-derived 
MSCs’ donor information.
Donor # Gender Age
1 female 65
2 male 41
3 female 64
4 female 40
5 female 18
6 female 20
7 female 40
8 male 41
9 female 55
Fig. 1. Experimental outline.
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streptomycin to reduce protein contamination from the 
serum in the secretome analysis (Fig.1).
RNA extraction and reverse transcription
RNA was extracted from cells with TRI reagent followed by 
on-column method (Qiagen, Hombrechtikon, Switzerland) 
as previously described (Czekanska et al., 2013). After the 
extraction, RNA samples were treated with RQ1 (RNA-
Qualified) RNase-free DNase to ensure very high quality 
of RNA samples. Manufacturers’ protocol was followed 
for DNase digestion. After the reaction, the enzyme and 
buffer components were removed with on-column RNA 
Clean-Up protocol (Qiagen). Reverse transcription of 
samples designated for the gene expression analysis with 
RT2 PCRArrays was performed using RT2 First Strand 
Kit according to the supplied instructions. For the gene 
expression analysis with Real-Time PCR, complementary 
DNA (cDNA) was transcribed from 0.5 µg total RNA using 
the TaqMan Reverse Transcription kit.
Cytokine gene expression analysis with RT2 
PCRArrays
The RT² Profiler™ PCR Array system containing primer 
assays for 84 cytokine genes of interest was applied to 
analyse the expression of human cytokine genes. Reactions 
were prepared according to the manufacturer’s instructions 
and run on StepOne Plus cycler (Applied Biosystems/Life 
Technologies, Foster City, CA, USA). Each plate was 
incubated for 10 min at 95 °C and followed by 40 cycles 
of PCR reaction at 95 °C for 15 s and 60 °C for 1 min. 
To confirm the absence of nonspecific amplification a 
dissociation curve was generated (60-95 °C for 20 min). 
After all reactions, the same threshold was set across all 
PCR array runs. Data was analysed with the SABiosciences 
PCR Array Analysis Web-based software. The mean of two 
housekeeping genes, β-2-microglobulin and RPL13A, was 
used for calculating ΔCT. Gene expression was calculated 
using the 2-ΔΔCT method.
Real-time PCR
Gene expression was analysed with TaqMan probes 
(Table. 2). RealTime-PCR was performed using StepOne 
Plus Real-Time PCR System (Applied Biosystems). The 
reactions were run for 2 min at 56 °C, 10 min at 95 °C, 
followed by 40 cycles of 15 s at 95 °C and 1 min at 
60 °C. Expression of the genes of interest in samples was 
normalised to RPL13a. Analysis of relative gene expression 
was performed using 2-ΔΔCT method. Expression levels of 
genes in MSCs stimulated with IL1β or SCF were made 
relative to the gene expression in unstimulated MSCs.
Conditioned medium (CM) collection and protein 
analysis
Medium conditioned by stimulated or unstimulated cells 
was collected and centrifuged at 1000 x g at 4 °C for 
20 min. Supernatant was transferred into fresh tubes and 
stored until required at -20 °C. The analysis of secrotome 
was performed using RayBio® Human Cytokine Antibody 
Array G-series 2000 (RayBiotech, Norcross, GA, USA), 
which enables detection and semi-quantitative evaluation 
of 174 cytokine proteins. Preparation of all reagents 
and procedure was followed according to the supplied 
instructions. Proteins present in the CM were detected 
using GenePix 4000B Microarray Scanner (Axon 
Instruments; Molecular Devices, Sunnyvale, CA, USA). 
The results were expressed as n-fold signal intensity 
compared to positive control samples. For further analysis, 
these results were normalised to the number of cells 
harvested after the collection of CM from cells stimulated 
or unstimulated cells. To estimate differences in protein 
synthesis between groups, n-fold change was calculated 
between stimulated groups and control.
Statistical analysis
The data included for statistical analysis are presented as 
means ± standard error (SE) of independent experiments. 
All obtained data underwent statistical analysis using SPSS 
Gene Order Code or Sequence
RPL13a (Housekeeping gene) Hs_01926559_g1
Alkaline Phosphatase Hs_00758162_m1
Sox9 Hs_00165814_m1
Interleukin-6 (IL-6) Hs_00985639_m1
Interleukin-8 (IL-8) Hs_00174103_m1
Interleukin-10 (IL-10) Hs_00961622_m1
TNFα Hs_01113624_g1
Wnt3a Hs_00263977_m1
Wnt4 Hs_00229142_m1
Wnt5a Hs_00998537_m1
Wnt7b Hs_00536497_m1
β-catenin Hs_00170025_m1
Runx2 forward: AGCAAGGTTCAACGATCTGAGAT
reverse: TTTGTGAAGACGGTTATGGTCAA
probe: TGAAACTCTTGCCTCGTCCACTCCG
Table 2. Primers and probes were purchased from Applied Biosystems, except for Runx2, 
where the primers and probe were purchased from Mycrosynth, CH.
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21.0 (Chicago, IL, USA) software package. Statistical 
significance at p < 0.05 of gene expression in stimulated 
cells compared to unstimulated cells was determined with 
Mann-Whitney U test.
Results
Influence of stimulation on cytokine gene expression 
by MSCs in serum-containing medium
The cytokine and growth factor gene expression analysis in 
MSC revealed donor dependent response to the stimulation. 
Yet, consistent effects at the mRNA level 72 h after 
stimulation were detected. Response to the treatment was 
assessed as positive if up- or downregulation of a gene 
occurred in cells obtained from at least 2 out of 3 donors 
compared to untreated controls (n = 3 for each factor 
and control). Due to differential sensitivity of cells from 
different donors to the stimulation, results are presented 
for each individual donor.
 A 2 h stimulation of cells with 10 ng/mL IL1β resulted 
in the upregulation of a wide range of cytokine genes 
72 h later. The highest upregulation was detected for 
BMP2, IL8, TNFSF11 and IL6 in cells from all three 
donors. BMP6 and NODAL were upregulated in 2 out 
of 3 donors. In addition, 2 cytokines, GDF5 and IL17B 
were downregulated in all three donors in response to the 
treatment (Fig. 2A).
 GCSF stimulation resulted in a pronounced upregulation 
of mRNA expression of 5 cytokines (BMP2, GDF9, 
IL10, (2/3 donors) IL8, NODAL (3/3 donors)) and 
downregulation of one cytokine (INFA1). Cells from all 
three donors consistently downregulated INFA1 gene 
expression compared to unstimulated cells (Fig. 2B).
 MSC stimulation with 100 ng/mL SCF resulted in high 
upregulation of IL1A and NODAL in all donors. As seen 
with GCSF stimulation, cells from donor 4 stimulated with 
SCF showed the lowest level of response. In addition, two 
of the donors (1 and 2) positively responded to stimulation 
by increasing the expression of GDF9 and TNFSF11 
compared to unstimulated cells. Interestingly, donor 4, 
who showed the lowest upregulation in IL1A and NODAL 
expression out of all donors, showed an opposite response 
regarding GDF9 and TNFSF11 in comparison to the two 
other donors (Fig. 2C).
 Transient stimulation with SDF1 modified the 
expression of 4 genes after 72 h. A high upregulation of 
NODAL gene expression was detected in response to SDF1 
treatment in all three donors. Additionally, stimulation 
had positive effects on two other cytokines, BMP8B and 
IL10, whereas IL1β was strongly downregulated in 2 out 
of 3 donors (Fig. 2D). The positive response to SDF1 
stimulation in IL1β regulation was detected in cells from 
donor 3.
Influence of a 2 h IL1β and SCF stimulation on 
cytokine gene expression by MSC in serum-free 
medium cell culture
In the time between stimulating the cells with either IL1β 
(n = 5) or SCF (n = 3) and mRNA sample collection, 
Fig. 2. Diagrams showing the mRNA levels of cytokines in MSC cells stimulated by IL1β (A), GCSF (B), SCF (C) 
and SDF1 (D). Cells in monolayer were stimulated with the specific factor for 2 h. Cells without any stimulation 
were included as controls for assessing regulatory effects of stimulation. Gene expression level in stimulated cells 
was expressed relative to control samples.
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Fig. 3. (A) mRNA levels of cytokines in MSC cells stimulated with IL1β. Cells in monolayer were stimulated with 
10 ng/mL IL1β for 2 h. Cells without any stimulation were included as controls for assessing regulatory effects of 
stimulation. The gene expression level from stimulated cells was made relative to control samples. (B) mRNA levels 
of cytokines in MSC cells stimulated with SCF. Cells in monolayer were stimulated with 100 ng/mL SCF for 2 h. Cells 
without any stimulation were included as controls for assessing regulatory effects of stimulation. The gene expression 
level from stimulated cells was made relative to control samples.
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some of the samples were maintained in serum-free 
DMEM medium. Forty eight hours after the stimulation 
with IL1β, mRNA expression of 20 cytokine genes were 
similarly regulated in at least of 3 out of 5 donors (Fig. 3A). 
Stimulation of MSCs with IL1β resulted in an upregulation 
of TNFRSF11B and IL1β and a downregulation of GDF5 
gene expression in all 5 donors (Fig. 3A). An increased 
mRNA expression in stimulated cells was detected for: 
BMP6, CD70, IL1α, IL6, IL8 and IL12A in 4 out of 5 
donors. On the other hand, various BMP-family members 
(BMP3, 4, 5 and 7), TGFβ3, GDF8, LTA and IL5 were 
downregulated in 4 donors. A positive response in GDF9 
and GMCSF gene regulation was detected in cells from 3 
donors. Similarly, 3 out of 5 donors downregulated BMP2 
gene expression after 2 h stimulation with IL1β (Fig. 3A).
 MSC from 3 donors were treated for 2 h with SCF. 
As a result, 12 cytokine genes showed response to the 
stimulation in at least 2 donors (Fig. 3B.). Eight of these 
genes were upregulated in cells from all 3 donors. More 
specifically, the mRNA level in stimulated cells relative 
to unstimulated cells was higher for BMP4, TNFRSF11B, 
TNFSF14, TGFβ2, INHBA, NODAL, IL1α and IL18. Due 
to an opposite response in regulation of TNFSF4, IL1β, 
IL17β and IL21 in cells from donor 5 or 9 (compared to 
other donors), these genes were upregulated only in 2 out 
of 3 donors (Fig. 3B).
 It has to be highlighted that overall the magnitude of 
the response was lower compared to the effect of IL1β on 
cytokine gene regulation. Approximately a 2-fold increase 
in gene regulation, relative to unstimulated controls, was 
detected after SCF stimulation. As an exception, cells from 
donor 7 were the most sensitive to SCF stimulation, which 
was marked by the highest increase of TNFSF14, IL1α, 
IL1β, IL18, IL21 and TNFSF4 mRNA level among all 3 
donors (Fig. 3B).
Regulation of the expression of osteogenic and Wnt 
signalling genes in MSCs stimulated with IL1β and 
SCF
The gene expression analysis of IL6, IL8, BMP2, RANKL 
was conducted to confirm the results obtained from RT2 
PCR array analysis (Fig. 4). Additionally, the components 
of the canonical and non-canonical Wnt signalling 
pathways, and osteogenic markers (Sox9, Runx2) were 
assessed at the mRNA level (Fig. 4). Similar to results from 
the cytokine gene expression arrays, the gene regulation in 
response to the stimulation was donor dependent. Out of 5 
donors, cells from donor 9 showed the opposite response 
to IL1β treatment than cells from other donors included 
in the analysis (Fig. 4A,C). Cells from the 4 other donors 
(donors 5-8) showed a similar trend in the response to 
IL1β. Hence, donor 9, as an outlier, was excluded from the 
statistical analysis. For stimulation with SCF, cells from 
all donors were included for the analysis of any significant 
differences in response to the stimulation.
 IL1β stimulation significantly downregulated mRNA 
expression of bone markers, including Runx2 (p = 0.02), 
Sox9 (p = 0.02), BMP2 (p = 0.01) and RANKL (p = 0.01) 
Fig. 4. Diagrams show the fold change gene expression in relative to control from each donor with the standard 
deviation, quantified by real-time PCR 48 h after the stimulation of MSC with IL1 β or SCF for 2 h. (A, C) Cells 
stimulated with IL1β; (B, D) Cells stimulated with SCF. Cells from 5 and 3 donors were stimulated with IL1β or 
SCF, respectively.
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(Fig. 5A). IL1β stimulation had no effect on the overall 
Runx2/Sox9 ratio compared to unstimulated cells 
(p = 0.468). Treatment with IL1β increased the expression 
of IL6 and IL8. Yet, this increase was significant only 
for IL8 (p < 0.001). Stimulation with SCF showed a 
negative effect on the regulation of Runx2, Sox9, BMP2, 
RANKL, IL6 and IL8 genes (Figs. 4B,5A). This decreased 
expression reached significance for Sox9 (p = 0.05), 
RANKL (p = 0.004) and IL8 (p = 0.004) (Fig. 5A).
 It was only possible to detect Wnt4 expression in cells 
from donor 8 and in donor 5 after the stimulation with 
IL1β and SCF (Fig. 4C,D). Moreover, mRNA expression 
of Wnt3 was not detected in any donor. Although, there 
were no significant differences in gene expression of Wnt5a 
(p = 0.748), Wnt7b (p = 0.3) or β-catenin (p = 0.748) 
between stimulated with IL1β and unstimulated cells, there 
was a trend of higher expression of Wnt7b compared to 
control (Fig. 5B). Stimulation of MSCs with SCF had no 
influence on the mRNA expression of Wnt5a (p = 0.256) 
or β-catenin (p = 0.73), whereas it significantly decreased 
Wnt7b expression (p = 0.008) compared to control (Fig. 
5B).
Influence of stimulation on cytokine protein secretion 
by MSCs in serum-free medium cell culture
The regulation of 174 cytokine proteins in response to IL1β 
or SCF stimulation was highly donor dependent, which 
prevented presentation of averaged results. Nevertheless, 
it was possible to analyse results in a manner similar to 
the gene expression results.
 The initial analysis of the fluorescence intensity of 
the medium samples collected from unstimulated cells 
revealed the secretion of 139 proteins by cells from donor 
5, 152 from donor 6 and 9, 154 from donor 7 and 153 from 
donor 8 (Table 3). For both treatments, the expression of 
Fig. 5. Diagrams show the mean fold change gene expression relative to control with the 
standard error of the mean, quantified by real-time PCR 48 h after the stimulation of MSC with 
IL1β or SCF for 2 h. (A) Expression of genes: Runx2, Sox9, Runx2/Sox9, BMP2, RANKL, 
IL6, IL8; (B) Expression of Wnt5a, Wnt7b and β-catenin. Gene expression was normalised to 
RPL13a and made relative to expression of genes in unstimulated cells. Statistical significance 
at p < 0.05 (*) of genes compared to unstimulated cells was determined with Mann-Whitney 
U test.
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proteins in conditioned medium (CM) was made relative 
to protein secretion into medium by unstimulated (control) 
cells. In case of IL1β stimulation, if cells from at least 3 
out of 5 donors showed similar regulation of proteins, the 
effect of stimulation was assessed as positive. Similar 
conclusions were made for SCF stimulation, when cells 
from at least 2 out of 3 donors responded to stimulation 
in similar fashion. All regulated cytokine proteins were 
grouped depending on their function (Fig. 7), showing 
that the 2 h stimulation with IL1β mostly influenced the 
secretion of proteins involved in chemotaxis, inflammation, 
angiogenesis and bone formation. The stimulation with 
SCF affected mitogenic, ECM and differentiation markers.
 Stimulation with IL1β influenced protein synthesis 
and secretion in MSC cells. Specifically, 18 out of 174 
analysed proteins were upregulated in the conditioned 
medium collected at 48 h from cells stimulated with IL1β 
and compared to conditioned medium from unstimulated 
cells (Fig. 6A). A lower secretion of 2 proteins, B7-1 and 
MIF, was observed in response to IL1β stimulation. Out 
of the upregulated 18 proteins, 9 of them, GCP2, GRO, 
ICAM3, IL8, MIP3α, RANTES, I309, IL6, IL2Rα and 
MCP3, were upregulated in cells isolated from all 5 
donors. This strongly indicates the regulatory role of IL1β 
on these cytokines. An increased expression of a further 
9 proteins, including Activin A, Amphiregulin, ENA78, 
FGF4, FGF9, GROα and LIGHT, was detected 48 h after 
IL1β stimulation in at least 3 of 5 donors (Fig. 6A).
 Among 174 proteins analysed from medium conditioned 
by MSCs stimulated with SCF, secretion of 15 of them 
were specifically regulated in response to the stimulation 
(Fig.6B). In relation to results from controls, SCF 
stimulation showed a negative effect on B7-1, sTNFRII and 
TIMP4 protein secretion in cells from all 3 donors. On the 
other hand, all donors showed a positive response to SCF 
stimulation by increased secretion of Amphiregulin, NAP2, 
Fig. 6. (A) Protein levels of cytokines in medium conditioned by MSCs stimulated with IL1β. Monolayer cells were 
stimulated for 2 h with 10 ng/mL IL1β. After stimulation, cells were washed with DMEM and maintained in DMEM 
with 1 % penicillin/streptomycin for 48 h. After that time conditioned medium was collected for the analysis of secreted 
proteins. (B) Protein levels of cytokines in medium conditioned by MSCs stimulated with SCF. Monolayer cells 
were stimulated for 2 h with 100 ng/mL SCF. After stimulation, cells were washed with DMEM and maintained in 
DMEM with 1 % penicillin/streptomycin for 48 h. After that time conditioned medium was collected for the protein 
secretion analysis.
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FGF4, GITR, IGFBP3, LIGHT, MDC, TIMP1. Basic FGF, 
BMP6, MIP1beta and TRAILR3 were upregulated in 2 out 
of 3 donors, with donor 9 being the exception (Fig. 6B).
Discussion
Immediately after tissue injury or trauma an inflammation 
response occurs, during which various molecules are 
released. These factors influence the behaviour and 
potential of cells involved in the regenerative process. 
Here, we investigated the longer term effects of a 
transient 2 h stimulation, with cytokines present during 
inflammation, on MSC gene expression and secretome. 
Few studies have been performed using a transient 
stimulation of MSCs in order to modify their phenotype. 
The short-term stimulation of human adipose derived stem 
cells with BMP2, to enhance osteogenic differentiation, 
showed superior results in a 3D biphasic calcium phosphate 
scaffold compared to a monolayer culture (Overman et 
al., 2013a). This occurred after a 15 min stimulation, 
suggesting it may be possible to reduce the 2 h used during 
this study. Moreover, the gene expression of trophic factors 
was differentially regulated in cells cultured in scaffolds 
compared to monolayer (Overman et al., 2013b).
mRNA analysis after 72 h of serum containing 
culture
In the initial set of experiments in serum-containing 
medium, PCR array results showed that even after only 
2 h stimulation of cells with each factor, a pronounced 
cell response was still detectable 72 h after treatment. 
This would be the critical engraftment time in a clinical 
setting. Stimulation with IL1β regulated the mRNA 
expression of the highest number of cytokine genes, 
emphasising its multifunctional role. Grouping the 
cytokines based on function can give some indication 
as to the overall effect that might be obtained. However, 
due to the complex interactions between the different 
cytokines, this would need to be further investigated in 
vivo to establish actual clinical benefit. These studies are 
currently planned. Cytokines, which responded to the IL1β 
treatment, take part in bone formation (BMP2, BMP6), 
angiogenesis (IL6, IL8), osteoclastogenesis (TNFSF11), 
development (NODAL), chondrogenesis (GDF5) and 
immunomodulation (IL17B). Specifically, only IL1β 
regulated the expression of BMP6, IL6, TNSFF11 and 
GDF5. SCF stimulation showed no effect on the gene 
expression of cytokines implicated in angiogenesis or 
bone formation. However, it upregulated genes involved in 
chondrogenesis (GDF9), immunomodulation (IL1A) and 
Fig. 7. Functional grouping of cytokines regulated by 2 h stimulation of bone marrow derived MSC cells with 10 ng/
mL IL1β or 100 ng/mL SCF. Colours indicate response to the stimulation: dark green – upregulation after stimulation 
with 10 ng/mL IL1β, light green – downregulation after 10 ng/mL IL1β stimulation, dark blue – upregulation after 
stimulation with 100 ng/mL SCF, light blue – downregulation, dark brown – upregulation by 10 ng/mL IL1β and 
100 ng/mL SCF, light brown – downregulation by 10 ng/mL IL1β and 100 ng/mL SCF. B7-1 = CD80 – cluster of 
differentiation 80; basic FGF – basic fibroblast growth factor; BMP4 – bone morphogenic protein 4; BMP6 – bone 
morphogenic protein 6; ENA78/CXCL5 – epithelial-derived neutrophil-activating peptide 78; FGF4 – fibroblast 
growth factor 4; GCP2 – granulocyte chemotactic protein; GITR/TNFRSF18 – glucocorticoid induced tumour 
necrosis factor receptor family related gene; GRO – growth-related oncogene; GROα – growth-related oncogene 
alpha; I309 = CCL1 – chemokine (C-C motif) ligand 1; ICAM3/CD50 – intercellular adhesion molecule 3; IGFBP3 
– insulin-like growth factor binding protein-3; IL2Rα – interleukin 2 receptor alpha; IL1β – interleukin 1 beta; IL6 
– interleukin 6; IL8 – interleukin 8; LIGHT = TNFSF14 – tumour necrosis factor ligand superfamily member 14; 
MIF – Macrophage migration inhibitory factor; MIP1β/CCL4 – Macrophage inflammatory protein-1 beta; MIP3α – 
Macrophage inflammatory protein-3alpha; NAP2 – neutrophil-activating protein-2; RANTES/CCL5 – regulated on 
activation, normal T cell expressed and secreted; SCF – stem cell factor; sTNFRII – soluble tumour necrosis factor 
receptor type II; TIMP1 – tissue inhibitor of metalloproteinase-1; TIMP4 – tissue inhibitor of metalloproteinase-4.
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Protein donor 5 donor 6 doonor 7 donor 8 donor 9
Angiogenin medium high high high high
BDNF low low low low low
BLC low low low low n.d.
BMP-4 low n.d. n.d. n.d. n.d.
BMP-6 n.d. n.d. n.d. n.d. low
CK beta 8-1 low low low low n.d.
CNTF low low low low low
EGF n.d. n.d. n.d. n.d. low
Eotaxin low n.d. n.d. low n.d.
Eotaxin-2 n.d. n.d. n.d. n.d. n.d.
Eotaxin-3 low low low low low
FGF-6 low low low low low
FGF-7 low low low low low
Flt-3 Ligand low low low low low
Fractalkine low n.d. n.d. n.d. n.d.
GCP-2 low low n.d. low n.d.
GDNF low low low low n.d.
GM-CSF low low low low low
I-309 low n.d. n.d. low n.d.
IFN-gamma low low low low low
IGFBP-1 low low low low n.d.
IGFBP-2 low low low low low
IGFBP-4 low low low low n.d.
IGF-I n.d. n.d. n.d. n.d. n.d.
IL-10 low low low low low
IL-13 low low low low low
IL-15 low low low low low
IL-16 n.d. n.d. n.d. n.d. n.d.
IL-1alpha low low low low low
IL-1beta low low low low low
IL-1ra low low low low low
IL-2 low low low low low
IL-3 low low low low low
IL-4 n.d. n.d. n.d. n.d. n.d.
IL-5 low low low low low
IL-6 high medium medium high high
IL-7 low low low low low
Leptin low low low low low
LIGHT low n.d. n.d. low n.d.
MCP-1 high high high high high
MCP-2 low low low low low
MCP-3 low low low low low
MCP-4 low low low low low
M-CSF low low low low low
MDC low n.d. n.d. n.d. n.d.
MIG low low low low low
MIP-1-delta n.d. n.d. n.d. n.d. n.d.
MIP-3-alpha low n.d. n.d. n.d. n.d.
NAP-2 low low low low n.d.
NT-3 low low low low n.d.
PARC low low low low low
PDGF-BB low low low low low
RANTES low low low low low
SCF low low low low low
SDF-1 low low low low low
TARC low low low low n.d.
TGF-beta 1 low low low low low
TGF-beta 3 n.d. n.d. n.d. n.d. n.d.
TNF-alpha low low low low low
TNF-beta low low low low low
Table 3. A-B. Cytokine protein levels secreted by unstimulated MSCs analysed using RayBio Cytokine Array G-Series.
Cells in monolayer were cultured for 48 h in serum-free medium. Protein level secreted by unstimulated MSCs (control) 
determined by the fluorescence signal intensity: n.d. (= not detected) – for the signal intensity up to 10; low – signal 
intensity of 10-1,000; medium – signal intensity of 1,001-10,000; high – signal intensity above 10,000.
Protein donor 5 donor 6 doonor 7 donor 8 donor 9
Acrp30 low low low low low
AgRP low low low low low
Angiopoietin-2 medium low low low low
Amphiregulin n.d. low low low low
Axl n.d. low low low low
bFGF n.d. low low low low
b-NGF n.d. low low low low
BTC low low low low low
CCL-28 low low low low low
CTACK low low low low low
Dtk n.d. low low low low
EGF-R low low low low low
ENA-78 n.d. low low low low
Fas/TNFRSF6 low low low low low
FGF-4 n.d. low low low low
FGF-9 n.d. low low low low
GCSF low low low low low
GITR-Ligand low low low low low
GITR n.d. low low low low
GRO medium medium medium medium medium
GRO-alpha low low low low low
HCC-4 low low low low low
HGF medium medium n.d. medium high
ICAM-1 n.d. low low low low
ICAM-3 n.d. low n.d. low low
IGFBP-3 n.d. low low low low
IGFBP-6 low low medium medium medium
IGF-I SR medium low low low low
IL-1 R4/ST2 low low low low low
IL-1 RI low low low low low
IL-11 low low low low low
IL-12 p40 n.d. low low low low
IL-12 p70 n.d. low low low low
IL-17 low low low low low
IL-2 Rapha low low low low low
IL-6 R n.d. low low low low
IL-8 low low low low low
I-TAC low n.d. low low low
Lymphotactin n.d. low low low low
MIF medium low medium low low
MIP-1alpha n.d. n.d. low low low
MIP-1beta n.d. low low low low
MIP-3beta n.d. low low low low
MSP-alpha low n.d. low low low
NT-4 low low low low low
Osteoprotegerin high high high high high
Oncostatin M low low low low low
PIGF low low low low low
sgp130 low low low low low
sTNF RII n.d. low low n.d. low
sTNF-RI low low medium medium medium
TECK n.d. low low low low
TIMP-1 medium medium medium medium medium
TIMP-2 high high high high high
Thrombopoietin low low low low low
TRAIL R3 n.d. low low low low
TRAIL R4 low low low low low
uPAR low medium low low low
VEGF low low low low low
VEGF-D n.d. low low low low
A B
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development (NODAL). Short-term stimulation of MSCs 
with GCSF positively regulated the response at the mRNA 
level of cytokines implicated in bone formation (BMP2), 
chondrogenesis (GDF9), angiogenesis (IL8, IL10) and 
development (NODAL) while it decreased the expression 
of IFNA1, which is involved in immunological responses. 
SDF1 stimulation uniquely regulated gene expression 
of the bone formation factor, BMP8b. Additionally, it 
stimulated the expression of an angiogenic factor (IL10) 
and downregulated expression of IL1β. Similarly, as 
with stimulation with other factors, a cytokine involved 
in developmental processes, NODAL, was upregulated 
in response to SDF1 stimulation. The regulation of 
different genes indicates that the potential of MSCs can 
be modulated depending on the aim of the application. 
Interestingly, the synergic effects of SCF and GCSF on 
stimulating proliferation and inhibiting differentiation 
of rabbit MSCs have been reported (Tang et al., 2009). 
It would be of interest to analyse whether the combined 
stimulation of MSCs with all or some of factors included 
in this study synergises and results in an even stronger 
response.
mRNA and secretome analysis after 48 h of serum-
free culture
Due to the high interest in IL1β-regulated osteogenic 
differentiation (Lee et al., 2010; Mumme et al., 2012; 
Sonomoto et al., 2012; Ferreira et al., 2013; Loebel et al., 
2014), and recent promising influence of SCF on tissue 
regeneration (Kim et al., 2011; Pan et al., 2013), our further 
investigations focused on a more detailed analysis of the 
direct effects of these two cytokines. We were particularly 
interested in regulation of cytokine genes and protein 
expression that could provide more predictable indications 
regarding the effects triggered by IL1β or SCF. To ensure 
that changes detected were specific for the stimulating 
factor used, and to allow for a more accurate protein 
analysis without contaminating serum proteins, the further 
investigations were performed after MSC stimulation in 
a serum-free medium for 48 h. Longer periods of serum-
free culture were not possible due to signs of cell distress.
 Interestingly, more pronounced effects on cytokine 
gene expression were detected at 48 h serum-free culture 
compared to results of the analysis made 72 h serum 
containing culture. After IL1β stimulation, 11 cytokine 
genes were upregulated and 9 cytokine genes were 
downregulated (Fig. 3A). BMP2, BMP6, IL6, IL8 and 
GDF5 showed the same response to IL1β treatment 48 
and 72 h after the stimulation.
 SCF resulted in the upregulation of 13 cytokine genes 
(Fig. 3B). Only TNFSF14 and IL1α, but not GDF9 and 
NODAL gene expression were upregulated 48 h after 
SCF stimulation, whereas all of these cytokines were 
upregulated 72 h after SCF treatment. These partial 
variances in the response to stimulation could be attributed 
to the differences in the time of the analysis of gene 
expression, i.e., 48 or 72 h, after the stimulation. It is 
highly probable that the expression of some of the genes 
increases or diminishes within a 24 h frame between both 
time points. In addition, the presence of serum in the initial 
set of experiments may also modify any response seen. 
Table 3. C. Cytokine protein levels secreted by unstimulated 
MSCs analysed using RayBio Cytokine Array G-Series.
Cells in monolayer were cultured for 48 h in serum-free 
medium. Protein level secreted by unstimulated MSCs 
(control) determined by the fluorescence signal intensity: 
n.d. (= not detected) – for the signal intensity up to 10; low 
– signal intensity of 10-1,000; medium – signal intensity 
of 1,001-10,000; high – signal intensity above 10,000.
Protein donor 5 donor 6 doonor 7 donor 8 donor 9
Activin A low low low low low
ALCAM low low low n.d. low
B7-1(CD80) n.d. low low n.d. low
BMP-5 low low low low low
BMP-7 low low low low low
Cardiotrophin-1 low low low low low
CD14 low n.d. low n.d. low
CXCL- 16 low low low low low
DR6 (TNFRSF21) low low low low low
Endoglin low low low low low
ErbB3 low low low low low
E-Selectin low low low low low
Fas Ligand low low low low low
ICAM-2 low low low low low
IGF-II medium medium medium medium medium
IL-1 R II low low low low low
IL-10 Rbeta low low low low low
IL-13 Ralpha2 low low low low low
IL-18 BPalpha low low low low low
IL-18 Rbeta low low low low low
IL-2 Ralpha low low low low low
IL-2 Rbeta low low low low low
IL-2 Rgamma low low low low low
IL-21R low low low low low
IL-5 Ralpha low low low low low
IL-9 low low low low low
IP-10 low low low low low
LAP medium medium medium medium medium
Leptin R low low low low low
LIF low low low low low
L-Selectin low low low low low
M-CSF R low low low low low
MMP-1 low low low low low
MMP-13 low low low n.d. low
MMP-9 n.d. low low n.d. low
MPIF-1 low low low low low
NGF R low low low low low
PDGF AA low low low low low
PDGF-AB low low low low low
PDGF Ralpha low low low low low
PDGF Rbeta low low low low low
PECAM-1 n.d. n.d. n.d. n.d. low
Prolactin low low low low low
SCF R low low low low low
SDF-1beta low low low low low
Siglec-5 low low low low low
TGF-alpha n.d. n.d. n.d. n.d. low
TGF beta2 low low low low low
Tie-1 low low low low low
Tie-2 low low low low low
TIMP-4 low n.d. low n.d. low
VE-Cadherin low low low low low
VEGF R2 low low low low low
VEGF R3 low low low low low
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The consistency of the data obtained from both serum 
containing and serum-free culture, increases the confidence 
in the changes observed. However, where differences were 
seen it must be taken into consideration that data from 
donors 1-4 was obtained during the serum containing 72 h 
experiment, while donors 5-9 were used for the serum-free 
48 h experiments.
 IL1β and SCF regulated gene expression of interleukin 
family members (Fig. 3). These cytokines are recognised 
for their pro-inflammatory role and destructive effects on 
bone in pathological conditions including osteoarthritis 
(Fernandes et al., 2002; Kapoor et al., 2011). Paradoxically, 
in the context of bone regeneration, the presence of 
some of these pro-inflammatory cytokines promotes 
the bone regeneration in multiple ways. Importantly, 
this positive effect strongly depends on the timing of 
their expression. Both, IL12 and IL18 inhibit in vitro 
osteoclast differentiation. In addition, IL18 directly 
induces production of IL6, which is known for its potent 
roles at early stages of the bone healing process (Gracie 
et al., 2003). In fact, IL6 together with IL8 are the major 
angiogenic factors stimulating vascular endothelial growth 
factor (VEGF) during fracture healing (Martin et al., 2009; 
Kolar et al., 2011). IL1β treatment increased the gene and 
protein expression of IL6 and IL8, whereas SCF had an 
opposite effect on gene expression of these cytokines, 
suggesting the involvement of IL1β, but not SCF, in 
triggering angiogenesis. On the other hand, the stimulatory 
effects of SCF on angiogenesis could potentially be 
mediated through the upregulation of IL18 cytokine gene 
expression inducing IL6 (Gracie et al., 2003).
 The gene expression of BMP superfamily members 
was lower in cells after IL1β treatment (Fig. 3A). 
BMPs are important for proliferation, osteoblastic 
and chondrogenic differentiation, morphogenesis and 
apoptosis. A heterodimeric association of BMP4/7 and 
BMP2/7 regulates the proliferation of MSCs and induces 
the differentiation of MSCs into osteoblastic lineage 
(Tsiridis et al., 2007). Similarly, BMP5 and TGFβ3 possess 
osteoinductive properties (Wozney, 2002). At the same 
time, BMP6, a factor implicated in chondrocyte maturation, 
was upregulated after the stimulation with IL1β. GDF5 and 
GDF8 are involved in chondrogenesis and callus formation. 
Additionally, GDF8, a negative regulator of skeletal muscle 
growth, stimulates the adipogenic differentiation in MSCs, 
whereas its absence increases osteogenic differentiation 
(Artaza et al., 2005; Hamrick et al., 2007). Interestingly, a 
positive correlation of GDF8 deficiency and fracture callus 
size in a mouse in vivo model was reported (Kellum et al., 
2009).
 In addition to the assessment of cytokine genes in 
response to 2 h stimulation of cells with IL1β and SCF, 
the expression of Wnt signalling pathway components 
and their relation to Sox9 and Runx2 transcription factor 
gene expression was analysed after 48 h of serum-free 
culture post treatment. The analysis of Wnt 3a, 4, 5a, 
7b and β-catenin mRNA expression in cells stimulated 
with IL1β or SCF relative to untreated cells was strongly 
donor dependent. This donor variation was also seen in 
the expression changes of other genes. The investigation 
of a stimulus on multiple donors is required in order to 
determine the frequency with which a response is observed. 
This is turn provides an indication as to its potential future 
clinical applicability.
 In the experimental setting within this study, the 
expression of Wnt3a was not detected in cells, neither 
with nor without IL1β or SCF stimulation. Wnt4 gene 
expression was detectable in control samples and in treated 
cells from 2 donors (5 and 8); whereas Wnt5a, 7b and 
β-catenin were expressed in stimulated and unstimulated 
cells. Both Wnt3a and Wnt4, together with β-catenin, are 
involved in the canonical Wnt pathway stimulating the 
expression of alkaline phosphatase (ALP), osteocalcin 
(OC), BMP2 and Runx2 (Kim et al., 2013), and inhibiting 
the non-canonical Wnt pathway (Boland et al., 2004). 
Importantly, the effect of canonical Wnt signalling on 
osteogenesis is highly dependent on the stage of target 
cells (Ling et al., 2009). Wnt5a and Wnt7b activate the 
non-canonical Wnt signalling pathway inducing several 
cascades, including planar-cell polarity (PCP), c-Jun 
N-terminal kinase (JNK), Nemo-like kinase (NLK) and 
Rho-associated kinase (ROK) signalling (Ling et al., 
2009). Our results indicated that although the stimulation 
with IL1β had no significant effect on Wnt5a, Wnt7b 
and β-catenin gene expression, Wnt7b showed a trend 
of increased expression upon the treatment with IL1β. 
This was in conjunction with a significant decrease in 
Runx2 and Sox9 gene expression. The treatment with SCF 
showed similar trends with significantly downregulated 
Wnt7b. The canonical Wnt signalling stimulates the 
differentiation of MSCs committed to osteogenic lineage, 
whereas it suppresses the terminal differentiation of mature 
osteoblasts (Ling et al., 2009). The former process is 
promoted through the upregulation of Runx2, which along 
with Sox9, is a transcriptional effector of the canonical 
Wnt signalling (Parr et al., 1993; Eames et al., 2004). 
Recent evidence showed that the promotion of osteogenic 
differentiation by IL1β is dependent on the non-canonical 
Wnt pathway stimulating Runx2 gene expression (Arnsdorf 
et al., 2009; Sonomoto et al., 2012). Although the 
expression of Runx2 and Sox9 was downregulated upon 
the stimulation of MSCs with IL1β or SCF, the Runx2/Sox9 
ratio remained at the same level suggesting that the short 
term treatment induces other mechanisms and outcomes in 
MSCs osteogenic differentiation in a monolayer culture.
 Secretome analysis revealed increased levels of 
proteins involved in the bone formation process (Fig. 7), 
in response to the short-term stimulation with IL1β or SCF.
 We observed an interesting association between 
the results from PCR and protein arrays regarding the 
expression and regulation of factors involved in fracture 
healing and bone remodelling. The results from post 
stimulation serum-free cultures showed the mRNA 
expression of Receptor activator of NF-κβ ligand 
(RANKL) was downregulated, whereas at the same time 
TNFRSF11b was upregulated in response to the stimulation 
with IL1β or SCF. RANKL is a paracrine factor involved in 
osteoblast-osteoclast progenitor cells cross-talk. Secreted 
RANKL protein binds to RANK receptor on the osteoclast 
progenitor cell surface activating the differentiation of the 
osteoclast phenotype (Udagawa et al., 1999). Interestingly, 
TNFRSF11b is a gene coding the osteoprotegerin (OPG) 
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protein, an inhibitor of osteoclastogenesis and activation 
of mature osteoclasts. In detail, OPG is the decoy receptor 
for RANKL expressed and secreted by osteoblasts and 
osteoprogenitor cells. The regulation of both OPG and 
RANKL is Wnt signalling dependent (Maeda et al., 2012; 
Maeda et al., 2013). Although, the protein level of OPG in 
the conditioned medium 48 h after the stimulation of MSCs 
with IL1β or SCF was at the same level as in untreated 
cells (data not shown), based on the mRNA expression 
level results, short term stimulation with IL1β or SCF 
strongly suggest the indirect inhibitory effects of these 
factors on the osteoclasts differentiation. Additionally, we 
reported Wnt pathway dependent regulation of OPG and 
RANKL in response to IL1β and SCF. The gene expression 
of additional factors inhibiting osteoclastogenesis was 
positively regulated in response to the stimulation. SCF 
treatment upregulated the expression of IL18, stimulating 
the production of osteoclast differentiation inhibitor, 
granulocyte macrophage colony-stimulating factor (GM-
CSF), by T-cells (Horwood et al., 1998; Gracie et al., 
2003). In the case of short-term stimulation of MSCs 
with IL1β, the expression of GM-SCF gene was directly 
upregulated after the treatment.
 Understanding the mechanisms involved in the indirect 
effects of preconditioning, i.e., due to the enhancement of 
the secretion of trophic factors acting in a paracrine manner, 
would be of great interest for cell-based regenerative 
therapies. Especially the relevance of the secreted factors 
after the stimulation in the context of bone regeneration 
would aid bone tissue regeneration strategies. Hence, it 
is crucial to further analyse the indirect effects of short-
term stimulation in the context of bone healing within a 
reliable in vitro cell culture model, which in reality should 
mimic endochondral ossification. In fact, it is challenging 
to recapitulate endochondral ossification, which occurs 
during bone formation or fracture healing, in in vitro 
conditions. The conventional monolayer in vitro models 
focus on the direct stimulation of osteogenesis which is 
alike intramembranous ossification but rarely occurs in the 
initial phase of fracture healing. The controlled stimulation 
of chondrogenic differentiation, followed by the osteogenic 
differentiation of MSCs in a 3D in vitro culture, results 
in formation of bone tissue via endochondral ossification 
(Muraglia et al., 2003; Scotti et al., 2010). Such models 
may be more suitable for future in vitro investigations into 
fracture healing.
Conclusions
The regeneration of bone is triggered by factors produced 
during the inflammation phase that occurs after trauma. 
These factors influence the behaviour of cells residing at 
the injury site by acting in a direct and indirect manner. 
Our results indicate the potential of a transient stimulation 
of cells by a number of factors to enhance the regulation of 
trophic factors over longer period of time. IL1β strongly 
promoted the secretion of a wide range of proteins with 
chemotactic, proinflammatory and angiogenic properties, 
suggesting it may have a greater influence in the early bone 
repair environment. Whereas SCF regulated the expression 
of proteins involved in proliferation, chondrogenesis and 
ECM regulation, indicating its use may be more beneficial 
in either cartilage repair or callus formation. This effect was 
achieved by a short stimulation, which could be applied as 
stem cell therapy strategy and performed intra-operatively.
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